Skip to main
ACHC

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare (ACHC) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 31%
Buy 23%
Hold 38%
Sell 8%
Strong Sell 0%

Bulls say

Acadia Healthcare Co Inc. is poised for a positive financial outlook due to its strong positioning within the rapidly growing behavioral health sector, where it has generated impressive organic growth through facility expansions and new developments. The expectation of a notable increase in net PLGL liability by the end of 2025, along with guidance for improved organic earnings growth, highlights the company's strategic focus on expanding its service capacity while navigating operational challenges. Additionally, the strong capitalization facilitates potential mergers and acquisitions, further positioning the company to enhance its market presence amid competitive conditions in the behavioral healthcare market.

Bears say

Acadia Healthcare Co Inc has lowered its EBITDA guidance for 2025 by approximately $94 million, or 13.4%, to a range of $601-611 million due to higher-than-expected PLGL expenses, which are projected to persist through 2026. The company anticipates a contraction in EBITDA for fiscal year 2026, estimating it at $626.6 million, down from a previous estimate of $664.6 million, which reflects ongoing litigation expenses that are significantly above historical norms. Moreover, the downside scenario suggests that volume softness could lead to EBITDA coming in 5% below current projections, resulting in a lower valuation multiple that is concerning for the company's long-term financial health.

Acadia Healthcare (ACHC) has been analyzed by 13 analysts, with a consensus rating of Buy. 31% of analysts recommend a Strong Buy, 23% recommend Buy, 38% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Acadia Healthcare (ACHC) Forecast

Analysts have given Acadia Healthcare (ACHC) a Buy based on their latest research and market trends.

According to 13 analysts, Acadia Healthcare (ACHC) has a Buy consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.85, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.85, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Acadia Healthcare (ACHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.